ASBM Highlighted in Inside Health Policy Article

May 16, 2012

After testifying before the FDA on May 11, Inside Health Policy quoted ASBM chairman Dr. Dolinar. Biologics makers peg biosimilars areas they want clarified: Alliance for Safe Biologics chairman Richard Dolinar said, “Biologics are complex, large molecule drugs that are grown inside living cells using unique and proprietary processes. For this reason no two biologics […]

Read More


Biologics: Are Unsafe Drugs an ‘Acceptable Risk?’ FDA Should Say ‘No!’

November 7, 2010

For cancer patients, what is the “acceptable risk” that a drug will pose safety risks or won’t work properly?

Read More